Decibel Therapeutics, a clinical-stage biotechnology company, has established the world’s first comprehensive drug discovery, development, and translational research platform for hearing and balance disorders.

Biotechnology

Decibel Therapeutics

Decibel Therapeutics' headquarters in Boston, MA, United States

Pete Weber

Bridget Cleff

Dr.Ranjith Kumar Chapala

Ulrich Mueller

Alan Cheng

Michael Greenberg

Matthew Kelley

Connie Cepko

Glenn Pierce

Dinah Sah

Kevin McLaughlin

Saraswathy Nochur

Gabriel Corfas

Guangping Gao

William H. Carson

Albert Edge

M. Charles Liberman

David Ginty

Dwight E. Bergles

The Advisory Team at Decibel Therapeutics comprises expert advisors and scientific consultants who provide strategic guidance and insights into the research and development of therapies for hearing and balance disorders. They leverage their extensive knowledge and experience to inform decision-making processes, mentor staff, and ensure alignment with industry best practices, ultimately driving innovation and enhancing the company's clinical and commercial success.

Advisory Team

The Leadership Team at Decibel Therapeutics is responsible for setting the strategic vision and direction of the company. They oversee the planning and execution of new product initiatives, program management, and operational strategies to drive innovation in drug discovery and development for hearing and balance disorders. Their collaborative efforts ensure alignment across various departments, facilitating the successful translation of research into impactful therapies.

Leadership Team

The Research and Development team at Decibel Therapeutics is dedicated to advancing innovative therapies for hearing and balance disorders. This multidisciplinary group conducts cutting-edge research, utilizes analytical techniques, and collaborates on clinical operations to translate scientific discoveries into effective treatments, ensuring the safety and efficacy of new drug candidates.

Research and Development

The Operations Team at Decibel Therapeutics is responsible for streamlining and optimizing the processes related to drug development and clinical trials for hearing and balance disorders. This team collaborates closely with various stakeholders to enhance patient experience, ensure compliance, and implement innovative strategies that drive the efficient progression of therapeutic programs from discovery through to clinical implementation.

Operations Team

The Corporate Strategy and Planning team at Decibel Therapeutics focuses on shaping the long-term vision and strategic framework of the company. This team is responsible for assessing market opportunities, driving new product initiatives, and ensuring alignment between cross-functional teams to support the development of innovative therapies for hearing and balance disorders. Their collaborative efforts facilitate informed decision-making that propels Decibel’s growth and operational excellence.

Decibel Therapeutics

Org chart

Board & advisors

Teams

Advisory Team

Leadership Team

Research and Development

Operations Team

Corporate Strategy and Planning

Offices

Decibel Therapeutics

Org chart

Board & advisors

Teams

Advisory Team

Leadership Team

Research and Development

Operations Team

Corporate Strategy and Planning

Offices

Related companies